Citation: Gd. Novack et al., CHANGE IN INTRAOCULAR-PRESSURE DURING LONG-TERM USE OF LOTEPREDNOL ETABONATE, Journal of glaucoma, 7(4), 1998, pp. 266-269
Authors:
BEEHLER C
BODNER B
BOWMAN B
COOKE D
CRABB JL
DEBARGE LR
DONNENFELD E
ESTOPINAL M
FOX K
KASTL P
OLANDER K
SHARPE E
SHOFNER R
STAHL J
STEVENSON D
STEWART W
WALTERS T
GILL S
HOWES J
LAWSON C
SMERICK M
ZACCARDELLI D
FAZIO R
NOVACK GD
CROCKETT RS
HART K
Citation: C. Beehler et al., A DOUBLE-MASKED, PLACEBO-CONTROLLED EVALUATION OF 0.5-PERCENT LOTEPREDNOL ETABONATE IN THE TREATMENT OF POSTOPERATIVE INFLAMMATION, Ophthalmology (Rochester, Minn.), 105(9), 1998, pp. 1780-1786
Authors:
DELL SJ
SHULMAN DG
LOWRY GM
HOWES J
BERDY G
EMBRY S
FOX K
HORWITZ B
KUNESHPART K
LAIBOVITZ R
LEVIN J
LOWRY G
ORLANDO R
PARKS D
WALTERS T
COULTAS S
HART K
CROCKETT RS
NOVACK GD
Citation: Sj. Dell et al., A CONTROLLED EVALUATION OF THE EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE IN THE PROPHYLACTIC TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS, American journal of ophthalmology, 123(6), 1997, pp. 791-797
Citation: Ae. Dwyer et al., ASSOCIATION OF LEPTOSPIRAL SEROREACTIVITY AND BREED WITH UVEITIS AND BLINDNESS IN HORSES - 372 CASES (1986-1993), Journal of the American Veterinary Medical Association, 207(10), 1995, pp. 1327